Navigation Links
PDL BioPharma Completes October 1 Special Dividend Payment
Date:10/4/2010

INCLINE VILLAGE, Nev., Oct. 4 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it has paid the October 1, 2010 special dividend payment of $0.50 per share to all stockholders owning shares of PDL as of September 15, 2010, the record date.

As previously announced, the conversion rate for the Company's 2.00% Convertible Senior Notes due February 15, 2012 was adjusted to 140.571 shares of common stock per $1,000 principal amount or $7.11 per share. The conversion rate adjustment went into effect September 16, 2010.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed by leading pharmaceutical and biotechnology companies today based on patents which expire in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.


'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Genesis Biopharma Announces $700K Private Financing
2. Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiple Myeloma Program Backed by Companion Diagnostics
3. Keryx Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference
4. Helix BioPharma Approved for NYSE Amex Listing
5. PDL BioPharma Provides Clarification Regarding Redemption of Its 2.75% Convertible Subordinated Notes
6. PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech
7. Reportlinker Adds Advances in Biopharmaceutical Technology in China
8. PDL BioPharma Announces Retirement of $61.6 Million of 2.75% Convertible Notes due August 2023 for Common Stock
9. Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated
10. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
11. Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Maryland (PRWEB) May 20, 2013 In ... in the field of biotoxin related illnesses , announced ... the country able to advance his protocol for treating ... Patel became the third physician to achieve certification in ... Certified Physicians, able to practice the Shoemaker Protocol in ...
(Date:5/19/2013)... York, NY (PRWEB) May 19, 2013 ... solar boat, today announced a new speed record for ... left from Las Palmas, Spain, on April 25, 2013, ... the Atlantic Ocean at the average speed of 5.3 ... West Indies on May 18, 2013. The first-of-its-kind catamaran ...
(Date:5/17/2013)... 2013 Topricin Pain Relief and ... been listed among nationally recommended over-the-counter (OTC) health ... by "U.S. News" Health in collaboration with "Pharmacy ... “No. 1 Pharmacists Recommended designation” in the “Topical ... brands, and is the only homeopathic formula to ...
(Date:5/17/2013)... 2013 Oven Industries Inc. announces a ... temperature controller has many user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... be used universally, which allows the user to use ...
Breaking Biology Technology:Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2New Temperature Control Products Announced by Oven Industries Inc. 2
... Western Pennsylvania Earn Designation, PITTSBURGH, March 11 ... General Hospital, UPMC Presbyterian Shadyside and UPMC,Passavant as ... Complex and rare cancers comprise approximately 15 ... difficult for patients to locate or,research facilities with ...
... SAN DIEGO, March 11 Cardium Therapeutics,(Amex: ... study being,conducted by researchers at Emory University, which ... ischemic myocardium,(heart muscle lacking sufficient blood flow as ... study employed an occlusion and reperfusion model,analogous to ...
... Passed Laws in 2007, but 26 Still Earn D,s or F,s on ... Legislation Report Card, ... population is now covered by state laws that,require insurance providers to cover the ... a coalition of 11 leading,public health groups. The enactment of new coverage laws ...
Cached Biology Technology:Highmark Blue Cross Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 2Highmark Blue Cross Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 3Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 2Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 3Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 4Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 5Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 6Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 7Colon Cancer Screening Laws Now Cover Half of U.S. Population 2Colon Cancer Screening Laws Now Cover Half of U.S. Population 3Colon Cancer Screening Laws Now Cover Half of U.S. Population 4Colon Cancer Screening Laws Now Cover Half of U.S. Population 5
(Date:5/17/2013)... Ill. An international team of ... structure and cell movement inside a living frog embryo ... a new method to advance biological research and the ... Northwestern University and the Karlsruher Institut fr Technologie in ... the U.S. Department of Energy,s Argonne National Laboratory, released ...
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... for Developmental Biology (SDB) 72nd Annual Meeting in ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... SDB 2013 Annual Meeting. , Awards are given ...
(Date:5/16/2013)... scientists have shown a gene involved in neurodegenerative disease ... of the circadian clock. , In a study ... gene, called Ataxin-2, keeps the clock responsible for sleeping ... the rhythm of the fruit fly,s sleep-wake cycle is ... for the fly. , The discovery is particularly ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Gene involved in neurodegeneration keeps clock running 2
... (mAbs) increases their toxicity to cancer cells, potentially improving ... conducted at Xencor, which will be published in the ... National Academy of Sciences (PNAS). , Monoclonal antibodies ... treatments for cancer, such as their specificity in targeting ...
... The cholesterol-lowering medications called statins do not appear to ... to a meta-analysis of previous studies in the January ... that statins reduce the risk of developing cancer, the ... "Statins have been studied in numerous large-scale, randomized, ...
... protein "watchdog" on high alert to stop hereditary cancers from ... a leash of just the right length. , In a ... M. Mendrysa has found that one of the proteins found ... of intestinal tumors that arise from genetic predisposition. When the ...
Cached Biology News:Data published in PNAS show antibodies can be made 10 times more toxic to cancer cells 2Statins have neutral effect on risk of cancer 2Loosen leash on cancer protein 'watchdog,' researchers say 2Loosen leash on cancer protein 'watchdog,' researchers say 3Loosen leash on cancer protein 'watchdog,' researchers say 4
... specifically for pulsed field separations of DNA larger than 2, ... megabase pairs. This agarose has the highest gel strength ... ... Grade, ...
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
AVOID FREEZE/THAW CYCLES. Recognizes the UCP-2 protein....
... new Vivaspin 2 bridges the gap between ... concentrators. This device combines the speed of ... surface and membrane area for superior recoveries ... a choice of PES, Cellulose Triacetate membranes, ...
Biology Products: